Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles - PubMed (original) (raw)
Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles
G M Reaven et al. J Clin Invest. 1993 Jul.
Abstract
Subjects characterized by a predominance of small LDL particles (pattern B) have changes in plasma triglyceride (TG) and HDL-cholesterol concentrations consistent with the presence of resistance to insulin-mediated glucose uptake. To pursue this issue, plasma glucose and insulin responses to oral glucose, insulin-mediated glucose disposal, and lipoprotein concentrations were measured in subjects categorized on the basis of LDL peak diameter measured by gradient gel electrophoresis. Subjects with pattern B had higher (P < 0.05-0.001) total integrated plasma glucose (20.7 +/- 1.0 mmol/liter.h) and insulin (1,743 +/- 293 pmol/liter.h) responses to oral glucose compared with glucose (16.3 +/- 0.4 and 19.2 +/- 0.8 mmol/liter.h) and insulin (856 +/- 60 and 1,222 +/- 168 pmol/liter.h) responses in those with either pattern A or an intermediate pattern. Pattern B individuals were shown to be more insulin resistant on the basis of higher steady state plasma glucose concentrations (SSPG, 10.4 +/- 1.0, P < 0.002, vs. 7.5 +/- 0.7 and 6.0 +/- 0.4 mmol/liter) after a constant infusion of somatostatin, glucose, and insulin than those with either the intermediate or pattern A subclass. Pattern B subjects also had higher concentrations of (P < 0.001) TG (1.98 +/- 0.15 vs. 1.33 +/- 0.17 and 0.77 +/- 0.05 mmol/liter) and lower (P < 0.01-0.001) HDL cholesterol (1.12 +/- 0.06 vs. 1.34 +/- 0.05 vs. 1.45 +/- 0.05 mmol/liter) than those with either the intermediate or pattern A. Finally, significant (P < 0.001) correlation coefficients existed between LDL diameter and SSPG (r = -0.44); glucose (r = -0.41) and insulin (r = -0.38) responses; TG (r = -0.65) and HDL-cholesterol (r = 0.42) concentrations; and systolic (r = -0.34) and diastolic (r = -0.34) blood pressure. Thus, pattern B subjects are insulin resistant, have higher glucose, insulin, and TG, lower HDL-cholesterol levels, and higher blood pressure than those with pattern A or intermediate.
Comment in
- Syndrome X: what's old, what's new, what's etiologic?
Ginsberg HN. Ginsberg HN. J Clin Invest. 1993 Jul;92(1):3. doi: 10.1172/JCI116566. J Clin Invest. 1993. PMID: 8325997 Free PMC article. No abstract available.
Similar articles
- Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women.
Palaniappan LP, Kwan AC, Abbasi F, Lamendola C, McLaughlin TL, Reaven GM. Palaniappan LP, et al. Metabolism. 2007 Jul;56(7):899-904. doi: 10.1016/j.metabol.2007.01.020. Metabolism. 2007. PMID: 17570249 - Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
Lepira FB, M'Buyamba-Kabangu JR, Kayembe KP, Nseka MN. Lepira FB, et al. Cardiovasc J S Afr. 2005 Sep-Oct;16(5):249-55. Cardiovasc J S Afr. 2005. PMID: 16307156 - Relations of plasma TG and HDL-C concentrations to body composition and plasma insulin levels are altered in men with small LDL particles.
Katzel LI, Krauss RM, Goldberg AP. Katzel LI, et al. Arterioscler Thromb. 1994 Jul;14(7):1121-8. doi: 10.1161/01.atv.14.7.1121. Arterioscler Thromb. 1994. PMID: 8018668 - Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
Goff DC Jr, D'Agostino RB Jr, Haffner SM, Otvos JD. Goff DC Jr, et al. Metabolism. 2005 Feb;54(2):264-70. doi: 10.1016/j.metabol.2004.09.002. Metabolism. 2005. PMID: 15690322 - Visceral fat accumulation contributes to insulin resistance, small-sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men.
Kobayashi H, Nakamura T, Miyaoka K, Nishida M, Funahashi T, Yamashita S, Matsuzawa Y. Kobayashi H, et al. Jpn Circ J. 2001 Mar;65(3):193-9. doi: 10.1253/jcj.65.193. Jpn Circ J. 2001. PMID: 11266194
Cited by
- Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.
Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S; Committee for Epidemiology and Clinical Management of Atherosclerosis. Kinoshita M, et al. J Atheroscler Thromb. 2018 Sep 1;25(9):846-984. doi: 10.5551/jat.GL2017. Epub 2018 Aug 22. J Atheroscler Thromb. 2018. PMID: 30135334 Free PMC article. No abstract available. - Tracking and determinants of LDL particle size in healthy children from 7 to 11 years of age: the STRIP Study.
Kaitosaari T, Simell O, Viikari J, Raitakari O, Siltala M, Hakanen M, Leino A, Jokinen E, Rönnemaa T. Kaitosaari T, et al. Eur J Pediatr. 2009 May;168(5):531-9. doi: 10.1007/s00431-008-0780-4. Epub 2008 Jul 5. Eur J Pediatr. 2009. PMID: 18604555 - Organic cation transporter 1 (OCT1) modulates multiple cardiometabolic traits through effects on hepatic thiamine content.
Liang X, Yee SW, Chien HC, Chen EC, Luo Q, Zou L, Piao M, Mifune A, Chen L, Calvert ME, King S, Norheim F, Abad J, Krauss RM, Giacomini KM. Liang X, et al. PLoS Biol. 2018 Apr 16;16(4):e2002907. doi: 10.1371/journal.pbio.2002907. eCollection 2018 Apr. PLoS Biol. 2018. PMID: 29659562 Free PMC article. - Fructose, insulin resistance, and metabolic dyslipidemia.
Basciano H, Federico L, Adeli K. Basciano H, et al. Nutr Metab (Lond). 2005 Feb 21;2(1):5. doi: 10.1186/1743-7075-2-5. Nutr Metab (Lond). 2005. PMID: 15723702 Free PMC article. - Pediatric non-high-density lipoprotein cholesterol, the metabolic syndrome, and insulin resistance.
Glueck CJ, Morrison JA. Glueck CJ, et al. J Pediatr. 2011 Feb;158(2):179-81. doi: 10.1016/j.jpeds.2010.09.016. Epub 2010 Oct 29. J Pediatr. 2011. PMID: 21035129 Free PMC article. No abstract available.
References
- Am J Hum Genet. 1988 Dec;43(6):838-46 - PubMed
- Biochem J. 1963 Jul;88:137-46 - PubMed
- Am J Med. 1989 Jan 23;86(1B):14-8 - PubMed
- J Clin Invest. 1967 Nov;46(11):1756-67 - PubMed
- J Clin Invest. 1970 Dec;49(12):2151-60 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous